Bifidobacterium bifidum-derived nanoparticles attenuate alcoholic liver disease via enhanced hepatic phagocytosis and gastrointestinal homeostasis. [PDF]
Gu Z +8 more
europepmc +1 more source
This review presents a pathology‐driven framework unifying nanomedicine across TBI, SCI, and PNI. Epidemiological evidence and comparative single‐cell transcriptomic reanalysis define shared pathological modules, injury‐specific effectors, and therapeutic bottlenecks. Six functional paradigms connect nanomaterial structure and biological fate to injury‐
Mouyuan Sun +12 more
wiley +1 more source
Epidemiology and clinical features of alcoholic liver disease in Hainan Province, China. [PDF]
Zhang DY +5 more
europepmc +1 more source
Recent Advances in High‐Entropy Nanozymes: From Fabrication to Applications
To highlight key achievements and clarify the current landscape of high‐entropy nanozymes (HEAzymes), this review summarizes state‐of‐the‐art developments ranging from thermodynamically and kinetically controlled synthetic strategies; enzyme‐like catalytic types, catalytic characteristics, and underlying mechanisms; to their antioxidative, therapeutic,
Yongjian Ai +8 more
wiley +1 more source
Advanced alcoholic liver disease driven by a proferroptotic diet. [PDF]
Liang Y +10 more
europepmc +1 more source
Tools for controlled selenol delivery are crucial for exploring Se‐related biology and medicine, but compound platforms for triggerable release of CH3SeH remain lacking. Herein, we report the first general triggered platform (TD‐MSe) for efficient cyclization release of CH3SeH in live cells.
Wenfang Liang +7 more
wiley +1 more source
Risk factors for significant hepatic fibrosis in alcoholic liver disease and construction of a nomogram prediction model. [PDF]
Jin M, Zhou J, He DM, Chen FL, Li HW.
europepmc +1 more source
Engineered Chiral Probiotics Ameliorate MASH via Gut–Liver Axis
A chiral gold nanozyme was coated onto the gut commensal bacterium Faecalibacterium duncaniae (F. duncaniae) to create an engineered probiotic. In mouse models of MASH, this orally administered living therapeutic protected the bacterium against oxidative stress, enhanced its gut colonization, reversed steatosis, inflammation, and fibrosis, and improved
Jing Chen +12 more
wiley +1 more source
Toll/IL-1 receptor domain-containing adaptor protein plays a crucial role in macrophage-mediated hepatic stellate cell activation in alcoholic liver disease. [PDF]
Patidar P +4 more
europepmc +1 more source

